Muen

Muen Cell is a biotechnology company focused on the development of next-generation natural killer (NK) cell therapies for the treatment of cancer and autoimmune diseases. The company utilizes its proprietary Muen-NK platform to engineer highly potent, off-the-shelf CAR-NK and NK cell products designed to overcome the limitations of current T-cell therapies. Their research emphasizes enhancing the persistence and infiltration of NK cells into solid tumors, which remains a significant challenge in immunotherapy. Muen Cell aims to provide scalable and cost-effective cellular medicines to patients globally through advanced genetic engineering and optimized manufacturing processes.